The link between cholesterol efflux by ABC transporters, inflammatory cytokines, and heart disease is becoming clearer with studies showing that inflammation can promote atherosclerosis by dampening the RCT pathway (Yvan-Charvet et al., 2007; McGillicuddy et al., 2009). The gene discussed is ABCG2; the disease is heart disorder.